Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05390918 · ClinicalTrials.gov registry record · NA

Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

A NA study of Insomnia and Suicidal Ideation, sponsored by Jeff Bridge.

Recruiting
Registry status
NA
Development phase
235
Enrollment target
1
Study location

NCT05390918 is a NA study of Insomnia and Suicidal Ideation that is actively recruiting participants, run by Jeff Bridge. The registered enrollment target is 235 participants, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (39% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05390918, a NA study of Insomnia and Suicidal Ideation, is actively recruiting participants, sponsored by Jeff Bridge.

RECRUITING
Registry status
NA
Development phase
235 participants
Enrollment target
1
Study location

Study Summary

This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from difficulties falling asleep, staying asleep, and/or insufficient sleep.

Interventions

  • OTHER Enhanced Usual Care
  • BEHAVIORAL TAILOR

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 235 participants
Start Date 2022-10-20
Est. Completion 2027-02
Phase NA

Sponsor

Jeff Bridge

2 total trials

What the Registry Record Tells You About NCT05390918

The ClinicalTrials.gov registry entry for NCT05390918 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 235 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 169-participant average among 151 other Insomnia trials with a reported enrollment target (39% higher). The listed sponsor is Jeff Bridge, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 2 interventions - of which Enhanced Usual Care is the first listed.

NCT05390918 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05390918 about?

NCT05390918 is a clinical study titled "Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior". This study will test the effectiveness of a sleep-related primary suicide prevention program entitled TAILOR (Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior), which includes specific behavior-change strategies for adolescents at risk of suicidal behavior who suffer from di...

What is the current status of trial NCT05390918?

This trial is currently recruiting. It is a NA study. The enrollment target is 235 participants. The study started on 2022-10-20. Estimated completion is 2027-02.

What conditions does trial NCT05390918 study?

This clinical trial studies the following conditions: Insomnia, Suicidal Ideation, Suicide, Attempted.

What interventions are being tested in trial NCT05390918?

The interventions under investigation include: Enhanced Usual Care (OTHER), TAILOR (BEHAVIORAL).

Who is sponsoring clinical trial NCT05390918?

This trial is sponsored by Jeff Bridge, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05390918 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.